U.S., May 2 -- ClinicalTrials.gov registry received information related to the study (NCT06952660) titled 'A Study to Learn More About TIVDAK in Women With Cervical Cancer That Has Come Back' on April 15.
Brief Summary: TIVDAK is used for the treatment of cervical cancer that has come back after chemotherapy. Chemotherapy is a treatment that uses medicines to stop the growth of cancer cells. This is done either by killing the cells or by stopping them from growing. The purpose of this study is to learn about possible side effects of TIVDAK, specially to any side effect that is related to the eye. A side effect is anything a medicine does to your body that is not part of how the medicine treats disease.
* This study is seeking for particip...